Congratulations #MillmanLab Dr. Marlie Maestas for successfully defending her PhD!

doing academic research right now

🚀 Ready to launch your postdoc journey? Check out WashU’s new Postdoc Passport for everything you need to get started. Register for the virtual event December 4th. postdoc.wustl.edu/prospective-...

Our qPCR data is now protected by sharks!

Congratulations #MillmanLab member Dr. Veronese Paniagua for successfully defending his PhD yesterday!

The #MillmanLab had a great time at the Breakthrough T1D walk yesterday! Happy to share our excitement for science with so many young people and support people living with #T1D!

The #MillmanLab is excited to be part of Vendor Village at the St. Louis @BreakthroughT1D Walk Sunday October 19! Come visit us to learn more about our cutting-edge research into stem cell-derived therapies for type 1 #diabetes and how we’re working toward a future without T1D.

The Millman Lab is proud to join the @BreakthroughT1D Walk in St. Louis on Oct 19 to support everyone living with type 1 diabetes. 🔗 Please consider donating to advance T1D research: www2.breakthrought1d.org/site/TR?fr_i...

Out today in @cp-cellreports.bsky.social! We found that coxsackievirus B3 (CVB3), associated with increased risk of #T1D, infects all human pancreas cell types, not just beta cells. Great collab w/ Hubert Tse (KUMC). Led by WashU DBBS PhD student Daniel Veronese-Paniagua www.cell.com/cell-reports...

[please retweet] I’m #hiring! The Millman Lab is looking for a postdoctoral researcher to lead an exciting new project focused on vascularized #stemcell-derived islets for #diabetes disease modeling and cell replacement therapy. Email me your CV and cover letter.

Join us for the 2025 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium. We have an amazing program this year focusing on type 1 #diabetes. We have also extended the abstract submission deadline to Sept 19. Register and submit your abstract a www.levinesymposium.com

A few days ago marked my 10th anniversary as a faculty member at Washington University School of Medicine in St. Louis. I arrived in 2015 as an Assistant Professor, excited but nervous to start my own lab. Today, I’m a Full Professor, reflecting on an incredible decade. 🧵

New application note from R&D Systems showcases efficient, reproducible generation of iPSC-derived pancreatic islets based on our 2021 Nature Protocols paper. High purity (75–80% C-peptide+/NKX6.1+) & robust glucose-stimulated insulin secretion www.rndsystems.com/resources/li... #T1D

I had the privilege to work with several experts in T1D as part of a June 2024 international Expert Forum at ADA organized by the editors of Diabetes, Diabetes Care, and Diabetologia to write a review article on T1D heterogeneity, check it out! diabetesjournals.org/diabetes/art...

New #diabetes publication in the NEJM. Sana Biotechnology provides evidence that gene-edited islets survive after transplantation into a patient without immunosuppressing drugs for several months www.nejm.org/doi/full/10....

When you say yes to just one more committee and now you're chairing it

Meet Allison Kelley, a technician at WashU’s Millman Lab! A Biomedical Engineering grad from UMiami, she authored a new paper in Biotechnology & Bioengineering and is shaping her career at the intersection of science, medicine, and patent law #womeninSTEM sites.wustl.edu/millmanlab/p...

Congratulations to @sydneal123.bsky.social‬ on publication of the main body of work from her PhD thesis, now out in the Journal of Biomedical Materials Research Part A! dx.doi.org/10.1002/jbm....

Big #T1D news! Vertex has published their phase 1–2 trial of stem cell-derived islets (VX880, now called zimislecel). All 12 full-dose patients had reduced insulin need, and 10 no longer require insulin injections. Major step forward to a functional cure! www.nejm.org/doi/full/10....

Looking forward to chairing the #ADA2025 session "Innovating Stem Cell Manufacturing and Engraftment Strategies for Cell Replacement Therapy" with many excellent speakers! Join us at 3:45p in room W196 BC.

PanKbase #ADA2025 spotlight: PI @annagloyn.bsky.social presents Sun. the 22nd at 2pm CDT. Session: Genetic Regulation of Beta-Cell Mass and Function in Humans: Lessons from GWAS and Rare Genetics. Her talk: "Integrating Multiomic Data to Understand Complex Gene Regulatory Networks in Islets"

Here at #ADA2025 in Chicago! Looking forward to learning about the latest research in diabetes and catching up with colleagues!

Will Kodner, a former summer high school student trainee, has rejoined the Millman Lab to continue his training as he prepares to begin his freshman year at WashU in the fall. Welcome back, Will!

Congrats to Millman Lab trainee Alice Smagorinsky on her selection for the 2025 @dkNET_Info Summer of Data Program! She'll sharpen her skills in data science, rigor & reproducibility, and data management over a 7-week immersive research experience.

Per Breakthrough T1D: We appreciate Hoda Kotb for opening up about her daughter Hope’s T1D diagnosis. A T1D diagnosis has an impact on the whole family, and the adjustment can be difficult. Thank you, Hoda, for sharing your story and helping raise awareness www.breakthrought1d.org/t1d-resources/

The RLM Postdoctoral Fellowship at WashU supports innovative, cross-disciplinary research with funding, mentorship, and a vibrant scientific community with non-federal funding Apply now: regenerativemedicine.wustl.edu/funding-2/rl... #StemCells #RegenerativeMedicine #PostdocOpportunity #WashU #Jobs

NIDDK is celebrating its 75th anniversary this year by releasing a collection of articles highlighting the advances made. I am happy that I could contribute to one on advances in cell replacement therapy. Check it out! diabetesjournals.org/diabetes/art...

WashU is accepting applications for Postdoctoral Fellowship in Diabetes & Related Metabolic Diseases (T32 DK007120). If you are eligible for T32 support (need to be a US citizen or permanent resident) and are interested in working with stem cell-derived islets, please contact me!

Millman Lab members and their families joined a cleanup in Wells-Goodfellow on Saturday for Earth Month. The event was part of an environmental justice series by earthday365 tackled illegal dumping and litter in underserved #StLouis neighborhoods.

Important diabetes news. Unfortunately, while VX264 (Vertex's encapsulated stem cell derived islet product) has been safe in patients, the company has discontinued the trial due to insufficient function of the cells. investors.vrtx.com/news-release...

WashU is pausing some construction projects (which provide jobs to people in Missouri), reducing the number of students admitted to some graduate programs, among other restrictions in response to the federal government. How is this improving the lives of voters in Missouri?

Breaking: The FDA's top vaccine official was pushed out and resigned today from the agency, @lizessleywhyte.bsky.social reports

It finally happened. I received my first peer review that was clearly written by AI.

This is as good an introduction as any - the reason why I am here. #StandUpForScience. Nice to see you all.

This vote was to start the process of the cuts. It WILL come back for a final vote. There are some chances to slow or potentially stop it. Need constant pressure on GOP Focus on GOP swing seats & key committees. Energy & Commerce is where the Medicaid fight will go down. Ways&Means for tax fight.

Penn to reduce graduate admissions, rescind acceptances amid federal research funding cuts www.thedp.com/article/2025...

ARPA-H director removed by Trump administration www.fiercebiotech.com/research/dir...

We made it on Cell's 2014-2024 timeline! :) #T1D #StemCells #CellTherapy www.cell.com/cell/abstrac...

I moved to Bluesky to avoid the toxicity on Twitter. But I have to be honest—engagement here has been disappointing. Despite everything, I still receive more constructive responses and support on Twitter. Bluesky needs to step up. @jay.bsky.team

While discussing the drastic reduction to 15% F&A for NIH grants, this very vocal person (with a blue check mark) on Twitter justified it through this message.

NIH is capping F&A at 15%. This will kill biomedical research.

Big #RegenerativeMedicine advance! New study demonstrates the use of iPSC-heart muscle to treat a patient with heart failure. The patches successfully engrafted, contributing to heart repair. Patient survived 3 months before receiving a heart transplant www.nature.com/articles/s41...

Meet the Researcher: Dr. Matthew Ishahak at the Millman Lab is leveraging #stemcell #organoid models & #singlecell sequencing to unlock new insights into human development and disease to advance precision medicine and regenerative therapies sites.wustl.edu/millmanlab/p...

Had to have the 'don't worry about AI's feelings but don't be mean' conversation with my child. the AI wanted to talk about dragons. had to tell my kid they wouldn't hurt its feeling to tell it they wanted to instead talk about zodiac signs. That isn't in the parenting guides...

New Millman lab publication out in Advanced Science using genetically engineered brain organoids to model glioblastoma (GBM). Excited to collaborate with Albert Kim to extend our stem cell expertise to cancer. Congrats 1st author Matt Ishahak advanced.onlinelibrary.wiley.com/doi/10.1002/...

Hello @washumedicine.bsky.social - Welcome to Bluesky! :) Let's share biomedical advances from WashU!

New study: Chronic intermittent fasting (IF) benefits β cell function in adults but impairs β cell maturation in adolescent mice. Long-term IF lowers insulin secretion and β cell mass, resembling patterns seen in Type 1 Diabetes #T1D www.cell.com/cell-reports...

Congratulations to Matt Ishahak, Marlie Maestas, Allison Kelley, Danny Veronese Paniagua, and Ed Sanchez-Castro for amazing poster presentations at HIRN earlier this week at NIH

Wrapping up an incredible two-day visit to NIH for the 10th Annual HIRN Conference! It was inspiring to learn about the latest advancements in T1D research and to share the Millman Lab's progress. Excited for future innovation in the field!

Thank you to Dr. Ishahak, Dr. Sneddon @juliesneddon.bsky.social, and Dr. Sims for serving on the panel for the Innovative Technologies in T1D Research at the 10th Year HIRN conference on T1D at NIH!